What is a peptide, in this context?

A short chain of amino acids used as a signalling molecule in topical formulation — intended to carry a message to cells rather than to act as a nutrient.

How does Biotinoyl Tripeptide-1 work?

It is formulated to act at the dermal papilla, which is where a growth signal has to land to matter.

Why do peptide products so often disappoint?

Two failures. Decorative dosing — an active present in quantities too small to do anything but appear on the label — and delivery to the wrong address, applied to hair rather than scalp.

Peptides and Hair: How Biotinoyl Tripeptide-1 and Peptide Complexes Support Aging Follicles

August 17, 2026

By Dr. Susan Lin, MD | MD HAIR | La Cañada Ventures, Inc.

You've seen the word everywhere. Peptides in your moisturizer. Peptides in your eye cream. And now — peptides for your hair. If you're standing in front of the mirror watching your part line widen and your hairline lose its density, you've probably wondered: is this just another marketing buzzword riding the skincare wave? Or is there real biology here — something that could actually matter for the follicles you're trying to save?

It's a fair question. And you deserve a real answer, not a slogan.

As a physician who has been formulating drug-free hair and scalp products since 2008, I've watched the peptide category evolve from a laboratory curiosity into one of the most scientifically interesting areas of cosmetic hair care. Peptides are not magic. But they are also not hype. They are precise biochemical messengers — and when the right peptide is delivered to the right place at a biologically meaningful concentration, it can speak directly to the cells that decide whether your follicle grows a strong hair or a weak one.

In this article, I want to walk you through what cosmetic peptides actually are, how signal peptides interact with the dermal papilla — the command center of the hair follicle — why concentration and delivery determine whether a peptide product works or is merely decorative, and where Biotinoyl Tripeptide-1 fits into an evidence-informed, drug-free regimen.

What Is a Peptide, Exactly?

A peptide is simply a short chain of amino acids — the same building blocks that make up every protein in your body, including the keratin in your hair. Where a full protein like collagen may contain over a thousand amino acids folded into a complex structure, a peptide may contain just two, three, or five. That small size is not a limitation. It is the entire point.

Your body uses short peptides as signaling molecules — chemical messages passed between cells. Hormone-releasing signals, wound-repair signals, growth-factor fragments: many of them are peptides. Cells carry receptors on their surfaces that recognize specific peptide sequences the way a lock recognizes a key. When the peptide docks, the cell changes its behavior — dividing, producing more of a protein, upregulating energy metabolism, or resisting an inflammatory insult.

Cosmetic science borrowed this principle. Instead of drugs that force a pharmacological change on the body, cosmetic signal peptides are designed to mimic the body's own messages — nudging cells toward behaviors they already know how to perform.

In hair care, the most studied cosmetic peptides fall into three broad families:

Signal peptides, which mimic natural growth and repair messages at the follicle (Biotinoyl Tripeptide-1 belongs here — a three-amino-acid sequence bonded to biotin).
Carrier peptides, such as copper-binding tripeptides, which shuttle trace elements like copper into tissue, where they support enzymatic repair processes (Pickart & Margolina, 2018).
Structural support peptides, which supply follicle and shaft-building amino acids in a form the scalp can readily use.

The distinction matters, because when a brand says “contains peptides,” it may mean any of these — or a token dusting of none-of-the-above. The question is never whether a product contains a peptide. It is which peptide, at what concentration, and delivered where.

The Dermal Papilla: Where the Signal Has to Land

To understand why signal peptides are interesting for aging follicles, you need to understand one structure: the dermal papilla.

At the base of every hair follicle sits a small cluster of specialized fibroblast cells — the dermal papilla. Think of it as the follicle's air-traffic control tower. The papilla does not make hair itself. Instead, it issues the instructions: it signals the surrounding matrix cells to divide, tells the follicle when to stay in anagen (the active growth phase), and largely determines the diameter of the hair shaft the follicle produces. Follicles with larger, more active dermal papillae produce thicker terminal hairs; follicles whose papillae shrink and quiet down produce progressively finer, shorter hairs (Paus & Cotsarelis, 1999).

This is why the dermal papilla is ground zero for the two great enemies of hair density:

Androgen signaling. DHT binds to androgen receptors concentrated in dermal papilla cells, and in genetically susceptible follicles this shifts the papilla's signaling output toward miniaturization — shorter growth cycles, finer shafts (Sawaya & Price, 1997).
Age- and stress-related quiescence. As we age — and under chronic stress — the signaling environment around the follicle deteriorates. A 2021 study in Nature showed that the stress hormone corticosterone suppresses GAS6, a key molecule that activates hair follicle stem cells; when the signal disappears, the stem cells simply stay dormant (Choi et al., 2021). The machinery is intact. The message to switch it on stops arriving.

Read that last sentence again, because it is the entire rationale for signal-peptide hair care: in much of age-related thinning, the follicle has not died — it has stopped receiving activating signals. The Wnt-family signals that maintain the papilla's hair-inducing activity are well documented in the developmental biology literature (Kishimoto et al., 2000). A signal peptide is an attempt to restore part of that conversation topically, without drugs and without touching your hormones.

How Biotinoyl Tripeptide-1 Works

Biotinoyl Tripeptide-1 is a small engineered molecule: the tripeptide glycine-histidine-lysine (GHK) — one of the most extensively studied repair-signaling sequences in the human body — bonded to biotin, the B-vitamin cofactor essential for keratin synthesis.

The design logic is elegant:

The GHK sequence is a naturally occurring fragment released during tissue repair. It has been studied for decades for its role in signaling regeneration, supporting the extracellular matrix proteins (collagen, laminin) that anchor the follicle, and improving the local tissue environment (Pickart & Margolina, 2018).
The biotin moiety improves the molecule's affinity for the follicle environment and brings a keratin-supportive cofactor along for the ride.

At the follicle, laboratory studies of this peptide have focused on the structures that matter most for a visibly thicker head of hair: the dermal papilla's activity and the anchoring proteins at the bulb — the “root sheath” infrastructure that keeps a growing hair seated firmly and supports a robust shaft.

And here is the point I find most compelling as a formulator: a signal peptide is designed to work at biologically active concentrations far below what pharmacological mechanisms require, because a signal only needs to reach its receptor. That efficiency is exactly what you would predict from a molecule designed to be a signal rather than a drug.

Why Concentration and Delivery Decide Everything

Here is the uncomfortable truth about the peptide category: most peptide hair products fail not because peptides don't work, but because of two entirely preventable formulation failures.

Failure 1: Decorative dosing

Peptides are expensive raw materials. It is common industry practice to add a peptide at a fraction of its studied concentration so it can appear on the ingredient label — what formulators privately call “fairy-dusting.” The peptide is present; the biology is not. When you evaluate any peptide product, the honest question is whether the peptide is included at or above the concentration used in the supporting laboratory work. If a brand cannot or will not speak to that, you have your answer.

Failure 2: Delivery to the wrong address

The dermal papilla sits at the base of the follicle, several millimeters below the scalp surface. A peptide sprayed over the hair shafts — the dead keratin you can see — accomplishes nothing for the living follicle. Effective delivery requires three things:

Direct scalp contact. The product must reach skin, not coat hair.
Targeted application. Thinning is not uniform. The hairline, crown, and part line are where miniaturization concentrates — and where every drop of a peptide serum should go. This is why I insist on precision applicators rather than broadcast sprays: they put a metered dose exactly on the zones under androgenic and age-related pressure, instead of wasting it across the lengths.
A vehicle that penetrates. The follicular opening is actually a privileged delivery route — actives applied to the scalp preferentially travel down the follicular canal, which is precisely where we want a follicle-directed signal to go.

Get the concentration right and the delivery right, and a peptide has a legitimate mechanistic path to the dermal papilla. Get either wrong, and you have purchased an expensive placebo.

Peptides and Drugs: Two Different Categories

I want to be careful and honest here, because this is where the category is most often oversold.

Minoxidil is a drug. It has regulatory approval as a hair-regrowth drug, a large evidence base, and a well-characterized mechanism involving potassium-channel activity and prolonged anagen (Messenger & Rundegren, 2004). For many people it is a reasonable choice, and nothing about a peptide regimen requires you to avoid it — MD HAIR products are designed to work with or without minoxidil.

But drugs come with drug characteristics, described in their own labeling and literature:

Dependence on continuous use, with rebound. When minoxidil is stopped, the hairs it was sustaining are shed — often within months.
Tolerability issues. Scalp irritation, unwanted facial hair growth in women, and the cosmetic burden of twice-daily dosing drive high real-world discontinuation.
A pharmacological mechanism that some users — women planning a pregnancy, the hormone-cautious, those on complex medication regimens — prefer not to add.

Cosmetic signal peptides sit in a different category — and let me say this plainly: they are not drugs, and they do not do what minoxidil does. They do not open potassium channels or force follicles into anagen. They are drug-free and hormone-free. They do not force a pharmacological state that collapses on withdrawal — so there is no rebound shedding phenomenon to fear when you stop. They support the follicle's own signaling and the appearance of density and shaft diameter; they do not diagnose, treat, cure, or prevent any disease, and I will never tell you otherwise. What they offer is a rational, well-tolerated, drug-free option addressed to the same hair concern — either as a foundation on its own or layered alongside a physician-supervised drug regimen. I make no claim that one is as effective as the other; they are different categories doing different things.

For the millions of people who cannot tolerate, cannot use, or simply do not want a daily pharmaceutical, that distinction is exactly the one that matters.

Realistic Timelines: What to Expect, and When

Hair biology is slow, and no honest formulator will pretend otherwise. Scalp hair grows roughly one centimeter per month, and a follicle's behavior only changes cycle by cycle. Here is the timeline I give patients for any follicle-directed regimen, peptide serums included:

Weeks 1–6: No visible change — and that's expected. The peptide is reaching follicles; nothing at the surface can have changed yet. Judge nothing in this window.
Months 2–3: The first meaningful markers: shedding may normalize, and the scalp environment improves. New fine regrowth at the hairline, if it comes, appears as short, soft “baby hairs.”
Months 3–6: This is the honest evaluation window. Emerging hairs have had time to lengthen; supported follicles produce shafts with a fuller look and better body. Compare photographs, not feelings.
Months 6–12: Cumulative benefit. Because each hair cycle is long, improvements compound over successive cycles — consistency is the entire game.

In our own consumer research — a 119-day Spincontrol study of the two-step topical system (24 participants, open-label, self-reported questionnaire, no placebo arm), in which 71% agreed their hair growth had improved, with the report itself noting that the overall satisfaction rate was not significantly validated; individual results vary — the timeline told the same story: the signal needs months, not weeks, to become visible.

Anyone promising a transformation in three weeks is selling you something other than biology.

The Bottom Line

Peptides are not a gimmick, and they are not a miracle. They are signaling molecules — and in the hair follicle, signaling is precisely what fails with age, stress, and androgen pressure. Biotinoyl Tripeptide-1 pairs one of the body's best-studied repair sequences with biotin, and it works on receptor logic: a message does not need to flood a tissue — it needs to arrive at the dermal papilla.

Choose a peptide product the way a physician would: demand the specific peptide, meaningful concentration, scalp-targeted delivery to the zones that are actually thinning, and a 3–6 month commitment before judgment. Do that, and you are giving your aging follicles the one thing they have stopped receiving on their own: instructions to keep going.

Dr. Susan Lin's Clinical Perspective

“When I evaluate a thinning scalp, I am rarely looking at dead follicles — I am looking at follicles that have gone quiet. The dermal papilla is still there; the stem cell reservoir is still there; what's missing is the activating signal. That is why I built our peptide serum around Biotinoyl Tripeptide-1 at a biologically active concentration and put it in a precision applicator rather than a spray: the hairline, crown, and part line are where the signal must land, drop by drop, day after day. A peptide will never behave like a drug — and that is its virtue. No rebound, no hormonal footprint, no reason it can't sit alongside minoxidil for patients who use one. The discipline it asks of you is simply time.”

— Dr. Susan Lin, MD, Physician Formulator, MD HAIR

Mechanism Spotlight: Why a Signal Works Differently Than a Drug

The most misunderstood number in peptide science is the concentration. A pharmacological agent must saturate tissue to alter cellular machinery broadly enough to shift a follicle's behavior. A signal peptide operates on receptor logic instead: the GHK sequence at the heart of Biotinoyl Tripeptide-1 is recognized by cellular machinery evolved to respond to it, the way your body responds to hormones circulating at vanishingly small concentrations. Receptor-mediated signaling is inherently catalytic — one docked molecule triggers a cascade inside the cell — while pharmacological flooding is inherently brute-force. That is a difference of kind, not of strength: I make no claim that a cosmetic peptide matches a drug's effect, and none that a drug is required to support the look of your hair. They are different tools. But the signal approach is what makes a drug-free, hormone-free, rebound-free serum possible at all.

MD HAIR Product Recommendation

MD® Follicle Energizer — Biotinoyl Tripeptide-1 peptide serum for the hairline, crown & part line

If the argument of this article resonates — that aging follicles need signal, delivered precisely, at a biologically active concentration — the MD® Follicle Energizer is that argument in a bottle. It delivers Biotinoyl Tripeptide-1 at a biologically active concentration to re-energize the look of aging follicles and support the appearance of hair-shaft diameter. The precision brush applicator is not a packaging flourish; it is the delivery system — a metered line of serum laid directly on scalp skin along the hairline, crown, and part line, exactly where miniaturization concentrates and where broadcast sprays waste product on hair shafts. It is a cosmetic, not a drug — it does not do what minoxidil does. It is drug-free and hormone-free, physician-formulated by Dr. Susan Lin, M.D., made in the USA in FDA-registered GMP facilities, and designed to work with or without minoxidil — as a foundation for those avoiding drugs, or as a follicle-supportive layer for those already on them. Individual results vary; give it the honest 3–6 months the biology demands.

Learn more about drug-free options at mdhair.com/pages/drug-free-hair-loss-treatment

References

Dr. Susan Lin, MD is the physician formulator behind MD HAIR, a line of drug-free, clinically informed hair-loss products by La Cañada Ventures, Inc., formulated since 2008 and made in the USA in FDA-registered GMP facilities. MD HAIR topical products are cosmetics; they are not drugs and are not intended to diagnose, treat, cure, or prevent any disease. This article is for educational purposes and does not constitute medical advice. Because there are no clinical data in pregnant or breastfeeding women, we do not advocate using MD HAIR products during pregnancy or lactation. Individual results vary. Consult your physician for personalized guidance.

Explore more in our Drug-Free Hair Regrowth series at mdhair.com/pages/drug-free-hair-loss-treatment